ATHN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ATHN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
athenahealth's change in receivables for the quarter that ended in Sep. 2018 was $17 Mil. It means athenahealth's Accounts Receivable declined by $17 Mil from Jun. 2018 to Sep. 2018 .
athenahealth's change in receivables for the fiscal year that ended in Dec. 2017 was $-8 Mil. It means athenahealth's Accounts Receivable increased by $8 Mil from Dec. 2016 to Dec. 2017 .
athenahealth's Accounts Receivable for the quarter that ended in Sep. 2018 was $167 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. athenahealth's Days Sales Outstanding for the three months ended in Sep. 2018 was 46.36.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. athenahealth's liquidation value for the three months ended in Sep. 2018 was $-92 Mil.
The historical data trend for athenahealth's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
athenahealth Annual Data | |||||||||||||||||||||
Trend | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | |||||||||||
Change In Receivables | Get a 7-Day Free Trial | -3.40 | -34.40 | -25.30 | -13.50 | -7.90 |
athenahealth Quarterly Data | ||||||||||||||||||||
Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | |
Change In Receivables | Get a 7-Day Free Trial | 6.50 | -5.70 | -32.80 | 16.30 | 16.50 |
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
athenahealth (NAS:ATHN) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
athenahealth's Days Sales Outstanding for the quarter that ended in Sep. 2018 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 167.4 | / | 329.5 | * | 91 |
= | 46.36 |
2. In Ben Graham's calculation of liquidation value, athenahealth's accounts receivable are only considered to be worth 75% of book value:
athenahealth's liquidation value for the quarter that ended in Sep. 2018 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 303.4 | - | 521.1 | + | 0.75 * 167.4 | + | 0.5 * 0 |
= | -92 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of athenahealth's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.
Brian P Mckeon | director | IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092 |
John A Kane | director | C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403 |
Dev Ittycheria | director | C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019 |
Ed Park | director | 311 ARSENAL STREET WATERTOWN MA 02472 |
Brandon H Hull | director | 221 NASSAU STREET, PRINCETON NJ 08542 |
Thomas J Szkutak | director | P O BOX 81226, SEATTLE WA 98108-1226 |
Jeffrey R Immelt | director, other: Executive Chairman | GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210 |
Marc A Levine | officer: Chief Financial Officer | C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472 |
Jacqueline B Kosecoff | director | 5960 HEISLEY ROAD, MENTOR OH 44060 |
Amy Abernethy | director | 311 ARSENAL STREET, WATERTOWN MA 02472 |
Kristi Ann Matus | officer: EVP and CFAO | C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104 |
Daniel H. Orenstein | officer: SVP, GC, and Secretary | 311 ARSENAL STREET, WATERTOWN MA 02472 |
Jeremy Delinsky | officer: SVP, Chief Product Officer | C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116 |
Timothy M Adams | officer: CFO & SVP | 311 ARSENAL STREET, WATERTOWN MA 02472 |
Bryan E Roberts | director | C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025 |
From GuruFocus
By Business Wire Business Wire • 12-22-2021
By Business Wire Business Wire • 12-14-2021
By Business Wire Business Wire • 07-07-2021
By Business Wire Business Wire • 12-09-2021
By Business Wire Business Wire • 12-03-2021
By Business Wire Business Wire • 12-27-2021
By Business Wire Business Wire • 12-28-2021
By Business Wire Business Wire • 05-04-2021
By Business Wire Business Wire • 12-30-2021
By Business Wire Business Wire • 10-18-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.